KAYLA STANAGE: Open Payments
NPI 1982133161 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 102 payments from 22 companies in 2025. Trend: 2023 $2,247 · 2024 $1,394 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $338 |
| Otsuka America Pharmaceutical, Inc. | 12 | $209 |
| Amgen Inc. | 11 | $161 |
| AstraZeneca Pharmaceuticals LP | 9 | $156 |
| Vanda Pharmaceuticals Inc. | 9 | $156 |
| Axsome Therapeutics, Inc. | 5 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Dexcom, Inc. | 3 | $50 |
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 3 | $49 |
Products named: REXULTI, AIRSUPRA, UBRELVY, Auvelity, VRAYLAR, HETLIOZ, OTEZLA, EVENITY.
Industry payments across AR — which companies pay providers there.
